The void and the brain.
Cell Reports July 22, 2025 DOI: 10.1016/j.celrep.2025.116072 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Volunteers inhaling a high dose of 5-methoxy-N,N-dimethyltryptamine |
| Interventions | 5-methoxy-N N-dimethyltryptamine |
| Dose | high dose |
| Topics | 5-MeO-DMT Altered states of consciousness |
| Keywords | Psychedelics Hallucinogens Entheogens Psychoactive compounds Brain research Neurobiology Brain activity EEG Neural state Brain function Mind Awareness Consciousness exploration |
| Citations | 1 |
| Key findings | The psychedelic 5-methoxy-N,N-dimethyltryptamine slows brain activity profoundly without significantly reducing alpha band power, a pattern atypical of other psychedelics. |
Abstract
Blackburne et al. track the electroencephalogram activity of volunteers inhaling a high dose of the powerful psychedelic 5-methoxy-N,N-dimethyltryptamine, revealing profoundly slowed-down brain activity but no significant reduction of alpha band power that is typical of other psychedelics.1.
Comparable studies
Other observational and cohort studies on 5-MeO-DMT, most cited first.
Citations in the library
Cited by 1
Cites 6
- Consciousness among delta waves: a paradox? Brain March 6, 2021
- The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) Journal of Neurochemistry February 12, 2022
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature June 1, 2024
- TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology. iScience May 19, 2023
- Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. Neuroscience of Consciousness 2025
and 1 more in the library